30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CONTROLLED-RELEASE FORMULATIONS 351<br />

Different types of modifi ed release systems can be defi ned [4, 8] :<br />

• Sustained release (extended release) that permits a reduction in dosing frequency<br />

as compared to the situation in which the drug is presented as a conventional<br />

form<br />

• Delayed release when the release of the active ingredient comes sometimes<br />

other than promptly after administration<br />

• Pulsatile release when the device actively controls the dosage released following<br />

predefi ned parameters<br />

In general, the sustained - release dosage form is designed to maintain therapeutic<br />

blood or tissue levels of the drug for an extended period of time. This is accomplished<br />

by attempting to obtain zero - order release from the designed dosage form.<br />

Zero - order release constitutes drug release from the dosage form that is independent<br />

of the amount of drug in the delivery system at a constant release rate. Systems<br />

that are designed for prolonged release can also be attributed as achieving<br />

sustained - release delivery systems. Repeat - action tablets are an alternative method<br />

of sustained release in which multiple doses of drugs are contained within a dosage<br />

form <strong>and</strong> each dose is released at a periodic interval, while delayed - release systems<br />

may not be sustaining, since often the function of these dosage forms is to maintain<br />

the drug within the dosage form.<br />

5.1.4 PHYSICOCHEMICAL AND BIOLOGICAL FACTORS<br />

INFLUENCING DESIGN AND PERFORMANCE OF<br />

CONTROLLED - RELEASE FORMULATIONS<br />

A number of variables, such as drug properties including stability, solubility, partitioning<br />

characteristics. charge <strong>and</strong> protein binding behavior, routes of drug delivery,<br />

target sites, acute or chronic therapy, the disease, <strong>and</strong> the patient, must be considered<br />

to establish the criteria for designing controlled - release products [9] . The performance<br />

of a drug in its release pattern from the dosage form as well as in the body<br />

proper is a function of its properties. These properties can at times prohibit placement<br />

if the drug is in a controlled - release form, restrict the route of drug administration,<br />

<strong>and</strong> signifi cantly modify performance for one reason or another. There is<br />

no clear distinction between physicochemical <strong>and</strong> biological factors since the biological<br />

properties of a drug are a function of its physicochemical properties while<br />

biological properties result from typical pharmacokinetic studies on the absorption,<br />

distribution, metabolism, <strong>and</strong> excretion (ADME) characteristics of a drug as well<br />

as those resulting from pharmacological studies.<br />

5.1.4.1 Physicochemical Factors<br />

Physicochemcial properties, such as aqueous solubility, partition coeffi cient <strong>and</strong><br />

molecular size, drug stability, <strong>and</strong> protein binding, are those that can be determined<br />

from in vitro experiments.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!